Research
Hormonal
High-protein diets promote weight loss and fat mass reduction while maintaining fat-free mass by increasing energy expenditure through diet-induced thermogenesis and stimulating anorexigenic hormones.
Consider increasing your protein intake to help with weight loss and preserving muscle. This works by boosting your metabolism and reducing hunger hormones. It is one of several effective dietary strategies.
ModerateSupportsMEDIUM confidence
An HPD promotes body weight and fat mass reduction while maintaining fat-free mass... High protein consumption elevates energy expenditure through diet-induced thermogenesis and increased resting metabolism. An HPD stimulates the release of anorexigenic hormones... and suppresses the release of ghrelin.
Why this rating
Based on review of existing studies cited in the paper.
Source
Obesity management in the Saudi population
Aljohrah Aldubikhi · Saudi Medical Journal · 2023
DOI 10.15537/smj.2023.44.8.20220724
narrative_reviewCited 22×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Lifestyle interventions, specifically combining dietary changes (low-calorie, low-fat, low-carbohydrate, high-protein, or low-glycemic-index diets) with exercise, are the first-line and fundamental treatment for obesity.Moderate
- COVID-19 lockdowns and associated lifestyle changes (reduced physical activity, increased screen time, comfort eating) led to significant weight gain and increased obesity prevalence in Saudi Arabia.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →